Regional Sales Director, Southeast

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions. The Regional Sales Director will lead a field sales team from pre-launch, training, launch excellence and sustainable sales achievements.

They will work with the field sales team and in partnership with all cross functional partners to support commercial excellence and positive experiences with all customer segments. The Regional Sales Director will ethically and compliantly deliver sales goals at or above targeted plans for all given measurement periods for their geographical areas of responsibility. Essential Job Functions Identify, recruit, hire, train, develop, motivate and retain top performing field sales personnel Prepare field-level action plans and lead and manage the behaviors needed to support the successful execution of the plans Field expert in market, competition, disease state, customer segments and commercial opportunity landscapes Understand and interpret sales and data reports and apply proactively and reactively clear and specific direction to drive specific behaviors and sales performance Establish and build key customer relationships to provide appropriate clinical and business support to drive area performance Effectively, efficiently and appropriately triage internal and external customer needs, issues and request in order to lower or remove barriers to core success factors Coach, teach and lead teams to engage customers in order to establish the foundation of disease awareness, appropriate patient profiles and compliant product utilization Execute recurring field visits with field team and provide timely written and verbal feedback Work with and partner with marketing, training, access and operations to deliver strategic imperatives while providing real-time feedback and suggestions on areas to continually improve organizational and operational excellence Constantly evaluate all internal and external factors in order to provide suggestions and guidance on more effective ways to meet and exceed goals Be the field facing lead for establishing the Kura Oncology name within the oncology-hematology community Fiscal responsibility and budget management to achieve maximize sales results Maintains highest level of compliance and ethics for self, team and organization Job Requirements Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration 10 years of pharmaceutical/biotech commercial experience within the oncology/hematology and/or rare disease markets, with a minimum of 5 years of experience managing direct reports and leading teams in oncology and/or rare disease Successful and documented track record of attracting, developing and retaining talent and building high performing teams Experience in pharmaceutical/biotech marketing, managed care/market access, commercial operations and/or sales training a plus Launch preparation and successful launch experience in oncology/hematology; rare disease experience a plus Strategic and analytical thinking as demonstrated by key projects/initiatives Strong cross-functional leadership skills and ability to collaborate effectively within various groups Managerial Courage Excellent written and oral communication skills Strong computer skills, notably WORD, EXCEL and POWER POINT The base range for the RSD is $270,000 - $300,000 per year with a target bonus of $90,000.

Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. Kura's Values that are used for candidate selection and performance assessments:

We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays (Including Summer & Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company's diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology's approach to drug development is focused on rapidly translating novel science into life-saving medicines.

Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts. Kura's pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806.

Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura's website atwww.kuraoncology.comand follow us onXandLinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.